|
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
RECRUITINGN/ASponsored by Biosense Webster, Inc.
Actively Recruiting
PhaseN/A
SponsorBiosense Webster, Inc.
Started2025-10-21
Est. completion2030-12-31
Eligibility
Age22 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT07227532
Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Eligibility
Age: 22 Years+Healthy volunteers accepted
Inclusion Criteria: * Symptomatic paroxysmal Atrial Fibrillation (AF) who, in the opinion of the investigator, are candidates for catheter ablation for AF * Refractory, intolerant, or contraindicated to Class I/III antiarrhythmic drugs (AAD) * Willing and capable of providing consent * Able and willing to comply with all pre-, post-, and follow-up testing and requirements Exclusion Criteria: * Previously diagnosed with persistent or long-standing persistent AF (more than \[\>\] 7 days in duration) * Previous surgical or catheter ablation for AF * Significant congenital anomaly or medical problem that in the opinion of the investigator would be a contraindication to catheter ablation for AF * Current enrollment in an investigational study evaluating another device or drug * Life expectancy less than 12 months * Any contraindications as defined in the Protocol
Conditions2
Atrial FibrillationHeart Disease
Locations5 sites
California
1 siteCommunity Memorial Hospital
Ventura, California, 93003
Florida
1 siteOrlando Health Heart and Vascular Institute
Orlando, Florida, 32806
Texas
1 siteTexas Cardiac Arrhythmia Research Foundation
Austin, Texas, 78705
Virginia
1 siteWinchester Medical Center
Winchester, Virginia, 22601
Wisconsin
1 siteMercy Hospital
Janesville, Wisconsin, 53548
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorBiosense Webster, Inc.
Started2025-10-21
Est. completion2030-12-31
Eligibility
Age22 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT07227532